Health ❯Healthcare ❯Patient Care

Chronic Conditions

Patient Care Medical Research Pharmaceuticals Clinical Trials Immunology Clinical Guidelines Drug Development Patient Outcomes Endocrinology Genetics

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

Phase 3 trial results reveal significant cholesterol reductions and a favorable safety profile, with a long-term outcomes study underway.

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial